ProteomEdge works with scientists across pharma, academia, clinical research and core facilities to make targeted mass spectrometry-based protein quantification more robust, scalable and accessible. In this series, external voices share how multiplexed qRePS-supported workflows can help move proteomics from discovery toward quantitative confidence.
From plasma discovery to quantitative confidence
Lekha Sleno, Professor at the Department of Chemistry, University of Quebec in Montreal (UQAM), Canada
How combining discovery proteomics, targeted workflows and qRePS-supported quantification can improve robustness when investigating liver disease biology and biomarker candidates.
Making absolute proteomics accessible
Carina Sihlbom Wallem, Head of the Proteomics Core Facility, University of Gothenburg, Sweden
A core facility perspective on lowering the barrier to robust, multiplexed absolute protein quantification for researchers across life science, translational research and precision medicine.
Looking beyond LDL and HDL
Tasso Miliotis, Biomarker Lead at AstraZeneca, Gothenburg, Sweden
How absolute apolipoprotein quantification can help pharma teams generate reproducible protein data across studies and explore biology that conventional lipid readouts may miss.
COMING SOON: CLINICAL TRANSLATION
From plasma biomarkers to recurrence risk
Jacob Odeberg, KTH / SciLifeLab, Stockholm, Sweden